Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol.

MLA

Abdel Raheem, Amr, et al. “Safety and Effectiveness of Collagenase Clostridium Histolyticum in the Treatment of Peyronie’s Disease Using a New Modified Shortened Protocol.” BJU International, vol. 120, no. 5, Nov. 2017, pp. 717–23. EBSCOhost, https://doi.org/10.1111/bju.13932.

APA

Abdel Raheem, A., Capece, M., Kalejaiye, O., Abdel-Raheem, T., Falcone, M., Johnson, M., Ralph, O. G., Garaffa, G., Christopher, A. N., & Ralph, D. J. (2017). Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie’s disease using a new modified shortened protocol. BJU International, 120(5), 717–723. https://doi.org/10.1111/bju.13932

Chicago

Abdel Raheem, Amr, Marco Capece, Odunayo Kalejaiye, Tarek Abdel-Raheem, Marco Falcone, Mark Johnson, Oliver G Ralph, Giulio Garaffa, Andrew N Christopher, and David J Ralph. 2017. “Safety and Effectiveness of Collagenase Clostridium Histolyticum in the Treatment of Peyronie’s Disease Using a New Modified Shortened Protocol.” BJU International 120 (5): 717–23. doi:10.1111/bju.13932.